PD

Padmini Devi Sadhanala

Active Director Director DIN 08314197
DIN 08314197 First appointment Dec 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Padmini Devi Sadhanala

Data last updated:

Padmini Devi Sadhanala is a Director at Common Man Remedies Private Limited (since 2018). The company operates in Healthcare.

DIN 08314197
Primary Designation Director
Industry Healthcare
First Appointment 26 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Common Man Remedies Private Limited U85100TG2018PTC129320
Director26 Dec 20182018Active

Board colleagues of Padmini Devi Sadhanala

NameDINCompanyDesignation
Sadhanala Aparna08314196Common Man Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Common Man Remedies Private Limited
Premium access

Shareholding and investment profile for Padmini Devi Sadhanala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padmini Devi Sadhanala

Padmini Devi Sadhanala currently holds 1 directorship: Common Man Remedies Private Limited (Director, since 26 Dec 2018).

Padmini Devi Sadhanala was first appointed on 26 Dec 2018 as Director at Common Man Remedies Private Limited.

The current boards of Padmini Devi Sadhanala's companies include Sadhanala Aparna (Common Man Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available